Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
About this item
Full title
Author / Creator
Bohula, Erin A , Wiviott, Stephen D , McGuire, Darren K , Inzucchi, Silvio E , Kuder, Julia , Im, KyungAh , Fanola, Christina L , Qamar, Arman , Brown, Conville , Budaj, Andrzej , Garcia-Castillo, Armando , Gupta, Milan , Leiter, Lawrence A , Weissman, Neil J , White, Harvey D , Patel, Tushar , Francis, Bruce , Miao, Wenfeng , Perdomo, Carlos , Dhadda, Shobha , Bonaca, Marc P , Ruff, Christian T , Keech, Anthony C , Smith, Steven R , Sabatine, Marc S , Scirica, Benjamin M and CAMELLIA–TIMI 61 Steering Committee and Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this cardiovascular safety trial, lorcaserin facilitated sustained weight loss without a higher risk of major adverse cardiovascular events than that with placebo in a high-risk population of overweight or obese patients.
Alternative Titles
Full title
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Authors, Artists and Contributors
Author / Creator
Wiviott, Stephen D
McGuire, Darren K
Inzucchi, Silvio E
Kuder, Julia
Im, KyungAh
Fanola, Christina L
Qamar, Arman
Brown, Conville
Budaj, Andrzej
Garcia-Castillo, Armando
Gupta, Milan
Leiter, Lawrence A
Weissman, Neil J
White, Harvey D
Patel, Tushar
Francis, Bruce
Miao, Wenfeng
Perdomo, Carlos
Dhadda, Shobha
Bonaca, Marc P
Ruff, Christian T
Keech, Anthony C
Smith, Steven R
Sabatine, Marc S
Scirica, Benjamin M
CAMELLIA–TIMI 61 Steering Committee and Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2094415680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2094415680
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1808721
